4th Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Obesity awareness as a medical condition Metastatic Breast Cancer Awareness Review of DEA processes and procedures

LobbyistCovered position, as disclosed
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

HR 2415, The Treat and Obesity Act of 2013 S. 1184, The Treat and Obesity Act of 2013 HR 1416, The Cancer Patient Protection Act of 2013

LobbyistCovered position, as disclosed
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1416 (113th), H.R. 2415 (113th), S. 1184 (113th)

Pharmacy PHA

FDA/DEA controlled substances scheduling processes and delays H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013 "Track and Trace" legislation S. 957, The Drug Supply Chain Security Act, "Track and Trace" legislation

LobbyistCovered position, as disclosed
STEPHEN D MCMILLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 957 (113th), H.R. 1919 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.